From McGill Labs to AI-Powered Precision Medicine: Building Ebovir
Document our journey building AI systems for precision medicine
When people hear the words genetic testing, they often imagine a simple PDF report.
But behind that report lies something much larger:
whole genome sequencing pipelines,
clinical interpretation systems,
laboratory infrastructure,
AI-assisted variant analysis,
and the challenge of transforming complex genomic data into something humans can actually understand.
At Ebovir, this is the problem space we work in every day.
From Research Labs to Precision Medicine
Ebovir was incubated from McGill University laboratories and later admitted into the CQIB biotechnology incubator in Quebec.
Our mission is simple:
Build technologies that make precision medicine more accessible, scalable, and clinically useful.
Today, our work spans across:
AI-powered genomic interpretation
Whole genome sequencing (WGS)
Diagnostic services
Cell therapy research
Exosome-based biotechnology
Medical aesthetic biotechnology products
Why Genetic Interpretation Is Still Difficult
Modern sequencing technologies can generate enormous amounts of genomic data.
The real challenge is interpretation.
A single genome can produce:
thousands of variants,
hundreds of reports,
and thousands of pages of medical information.
Most patients — and even many clinicians — do not have the time to manually connect:
research papers,
variant databases,
clinical significance,
and personalized risk analysis.
This is where AI becomes important.
Building AI-Assisted Genomic Interpretation
At Ebovir, we are building systems that combine:
sequencing pipelines,
mutation databases,
literature-based knowledge graphs,
and AI-powered interpretation systems.
Our workflow includes:
Sequencing data processing
AI-assisted mutation detection
Mutation interpretation
Knowledge database integration
Interactive report generation
The goal is not just generating reports.
The goal is helping people understand what their genomic information actually means.
Building Canada’s AI-Driven Genomic Infrastructure
One of the areas we are particularly focused on is AI-assisted whole genome sequencing interpretation.
Our platform integrates:
large-scale genome databases,
scientific literature,
proprietary prediction models,
and continuously updated medical knowledge.
Some of the systems we are actively exploring include:
AI-based mutation interpretation
knowledge graph systems
genomic literature retrieval
clinical summarization pipelines
interactive patient-facing AI systems
As AI engineers, one thing became clear very quickly:
Medical AI is not only about models. It is about reliability, traceability, safety, and clinical usability.
That realization heavily shaped the architecture we are building today.
Beyond Software: Real Diagnostic Infrastructure
Unlike many AI startups that only build software layers, Ebovir also operates diagnostic laboratory infrastructure in Canada, including Biosafety Level II and III laboratories.
This matters because real-world clinical AI requires:
validated workflows,
reliable biological data,
laboratory integration,
and continuous collaboration between engineering and clinical domains.
Research Areas We Are Exploring
Our broader research and development efforts include:
AI + RNA Drug Development
Using AI-assisted RNA candidate generation and lung-targeted delivery systems for antiviral research.
Whole Genome Sequencing
Building interpretation pipelines for large-scale genomic reports and personalized health insights.
Early Cancer Screening
Exploring cfDNA and ddPCR-based screening systems for early detection workflows.
Precision Medicine Platforms
Creating AI systems capable of assisting both clinicians and patients with complex medical interpretation.
The Engineering Challenge Behind Medical AI
One thing we learned while building this system:
Medical AI products are fundamentally infrastructure problems.
You are not simply generating text.
You are handling:
scientific uncertainty,
patient-sensitive information,
continuously evolving research,
compliance constraints,
and clinical reliability requirements.
This is why our engineering efforts focus heavily on:
scalable cloud architecture,
structured medical data pipelines,
retrieval systems,
validation workflows,
and explainable AI interactions.
What Comes Next
This blog will document our journey building AI systems for precision medicine.
We plan to share:
RAG architecture lessons
genomic AI workflows
medical AI reliability challenges
cloud infrastructure decisions
compliance considerations
and practical engineering experiences from deploying real-world healthcare AI systems.
If you are interested in:
AI for healthcare,
genomics,
medical infrastructure,
or precision medicine engineering,
you are in the right place.
Welcome to the journey.
We are building safe technology for your genetic journey.
Proudly introduce about our products here https://ebovir.ca/
